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Interventions are needed to improve health outcomes by increasing the practice of 
evidence based medicine (EBM). Patient mediated interventions have been little 
studied but hold promise: they target identified barriers to EBM and particular types 
of patient mediated intervention have shown success. Furthermore, consumers are 
now being given information about evidence but the effects of this on EBM have yet 
to be properly assessed. 
The aim of this study was to show whether informing patients about research 
evidence leads to improved application of that evidence in their medical care. The 
study trialed a relatively low cost manual, developed using current best practice, 
which summarised Cochrane Reviews of evidence. The study focused on chronic 
obstructive pulmonary disease (COPD), a high-cost, high-burden chronic disease, 
showing a large gap between evidence and clinical practice. 
The study comprised a controlled before-and-after trial and a process evaluation. 
The trial assessed the success of this manual in changing medical practice for three 
indicator treatments (influenza vaccination, bone density testing and pulmonary 
rehabilitation) and in changing patient quality of life, knowledge, communication 
with doctor, satisfaction with information and anxiety. Results were analysed by 
median split of socioeconomic disadvantage. At 3 months the manual was associated 
with lower anxiety for participants with lowest socioeconomic disadvantage. At 12 
months the manual was associated with higher pulmonary rehabilitation enrolment 
for participants with greatest socioeconomic disadvantage. Other outcome measures 
showed no significant change.  Limitations included loss of power from unexpectedly 
good baseline care and adjustments for baseline differences.  The process evaluation 
showed that the manual was read more than a control pamphlet at both 3 and 12 
months but a minority of manual recipients reported talking to their doctor about 
topics from the manual. Very little treatment change was reported. Patient attitudes  
ix 
to evidence and doctor/patient communication norms appeared to be barriers for 
this patient group.  
New protocols for the design of behavioural interventions provide a framework 
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